• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Ramipril
    5 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    Ramipril Plus Teva
    Teva
    RX
    partial basket chart
    Multiple ingredients
    Ramipril Plus Teva

    ACE Inhibitor, Thiazide. Hydrochlorothiazide 12.5 mg, 25 mg, Ramipril 2.5 mg, 5 mg.
    SCORED TABLETS: 30. Accord. desired
    antihypertens. effect and pt’s tol. to the
    drug. Initial: 2.5 mg ramipril/12.5 mg
    HCT, If necess., dose may incr. at
    intervals of 2-3 wks. Max. dly dose: 10
    mg ramipril/50 mg HCT. Admin. in
    morn. as single dose. In most cases,
    blood press. will fall suffic. after 2.5 mg
    ramipril/12.5 HCT or 5 mg ramipril/25
    mg HCT dly. Pts pre-treated with
    diuretics: Discont. diuret. at least 2-3
    days bef. start. tmt or at least reduc.
    diuret. If discont. imposs., initiate tmt.
    with smallest possible dose (1.25 mg)
    dly in free combinat. Subsequent.
    change to dly dose of max. 2.5 mg
    ramipril/ 12.5 mg HCT. Ren. impair. pts:
    Creatinine clear. 60-30 ml/min/1.73 m2
    body surface: Initial: ramipril alone:
    1.25 mg dly. Aft. grad. incr. dose, start
    combinat. prep: with 2.5 mg
    ramipril/12.5 mg HCT dly. Max dly
    dose: 5 mg ramipril/25 mg HCT. Impair.
    liver funct: Response to tmt. may be
    increased/reduced. Tmt. must
    therefore be initiated only under close
    medic. vis. Max. dly dose: 2.5 mg. Tabs.
    to be swallowed whole with liq.
    (approx. 1/2 glass) before/during/after
    meal. Not to be chewed or crushed.
    Not for child.
    Essent. hypertens. when blood press.
    cannot be adeq. lowered with ramipril
    alone.
    C/I: Hypersens. to ramipril, any other ACE
    inhib., HCT, other thiazide diuret.,
    sulfonamides, any other ingred. of the
    prep. History angioneurot. edema;
    severe impair. ren. funct; dialysis pts, pts.
    with hemodynamic. relevant ren. art.
    stenos., bilat./unilat. in the single kidney.
    Pts. with hemodynamic. relevant leftventric.
    inflow/outflow imped. (e.g.
    stenos. aort./mitral valve); pts. with clinic.
    relevant electrolyte disturbs. which may
    worsen follow. tmt, e.g. hypokalem.,
    hyponatrem., hypercalcem., severe
    impair. liver funct., pregn., lact., concom.
    use ACE inhibit., extracorporeal tmt. lead. to contact of blood with negatively
    charged surfaces must be avoided (may
    lead to severe anaphylact. react.). Such
    tmts incl: dialysis or hemofiltrat. with
    certain high-flux membranes and low
    density lipoprotein apheres. with
    dextran sulfate.

    Ramipril Teva
    Teva
    RX
    partial basket chart
    Ramipril Teva

    ACE Inhibitor. Ramipril 2.5, 5, 10 mg.
    SCORED TABS: 30 x 2.5 mg; 28, 30 x 5 mg, 10 mg. May be taken irrespect.
    of food. Not for child. Hypertens:
    Initial. 2.5 mg dly, may be doubled in
    2-3 wks. Maint: 2.5-5 mg dly. Max: 10
    mg dly. Diuretic or calc. antag. may be
    added instead of increas. dose beyond
    5 mg dly. Impair. ren. funct: Initial: 1.25
    mg dly; max 5 mg dly. Impair. hep.
    funct: Init. under med. vis., max. 2.5 mg
    dly. CHF: Initial: 1.25 mg dly, may
    double to 2.5 mg in 1-2 wks. If 2.5 mg
    or more is req., this may be taken as a
    single dose or as 2 div. doses; max. 10
    mg dly. Impair. ren. funct: 1.25 mg dly;
    max. 5 mg dly. Impair. hep. funct:
    Initial. under med. vis., max: 2.5 mg dly.
    Follow. M.I: Initial: 5 mg dly, in 2 doses
    of 2.5 mg morn. and even; if not
    tolerat., then 1.25 mg 2 x dly; may be
    doubled in 1-3 days; max: 10 mg dly.
    Severe NYHA IV heart failure: 1.25 mg 1
    x dly. Impair. ren. funct: 1.25 mg dly;
    max: 5 mg dly; may be doubled after 1
    wk; then after a further 3 wks. increas.
    to 10 mg. Maint: 10 mg 1 x dly.
    Progress. ren. fail in pts with persist.
    proteinuria in excess of 1 g/day: 1.25
    mg 1 x dly, to be doubled in 2-3 wks.
    No data above 5 mg dly.
    Hypertens. CHF, reduct. mortality aft. M.I.
    with LV dysfunct., reduce risk M.I., stroke,
    CV death, need for revasc. proced. in pts.
    over 55 yrs who have clinic. evidence of
    CVS dis., stroke or periph. vasc. dis.
    Reducing risk of M.I., stroke, CVS death or
    need for revasc. proced. diabet. pts over 55
    yrs who have: hypertens., high total
    cholesterol, low HDL, current smokers; known microalbuminur.; clin. evidence of prev. vasc. dis. Prevent. progress. ren. fail. in pts. with persist. proteinuria in excess of 1 g/day.
    C/I: Hypersens. to product or other ACE
    inhib.; hist. of angioneurot. edema; pts
    with hemodynamic. relev. ren. art.
    stenos.; bilat. or unilat. in the single
    kidney; pts with hypotens. or
    hemodynamic. unstable state. Pregn.,
    lactat. Avoid concomit. use of ACE inhib.
    and extracorporeal tmts. leading to
    contact of blood with negatively
    charged surfaces as can lead to severe
    anaphylact. reacts. Pts. with
    hemodynamic. relev. LV inflow/outflow
    impediment.

    Ramitens
    Rafa
    RX
    partial basket chart
    Ramitens

    ACE Inhibitor. Ramipril 10 mg.
    CAPS: 10 mg.
    Hypertens., CHF, reduct. mortality aft.
    M.I: Initial. (for pts. not on diuretics):
    2.5 mg 1 x dly. May incr. at intervals of
    2-3 wks. up to 5 mg 1 x dly to max: 10
    mg 1 x dly. Reduct. risk M.I, stroke or
    CV death and/or need for
    revascularizat: Initial: 2.5 mg 1 x dly.
    Depend. On tolerabil. grad. incr. to
    double after approx. 1 wk; aft. further
    3 wks. incr. to 10 mg. Maint: 10 mg 1 x
    dly. Pts already stabilized on lower
    doses for other indicats., where
    possible should be titrated to 10 mg 1
    x dly.
    Hypertens. congest. heart fail., reduct.
    mortality aft. M.I. with left ventric.
    dysfunct., reduce risk M.I., stroke, CV
    death, need for revascularizat. in pts. over
    55 yrs who have clinical evidence of CV
    dis. (prev. M.I., unstable angina,
    multivessel CABG or PTCA), stroke or
    periph. vasc. dis. Also for reducing risk of
    M.I., stroke, CV death or need for
    revascularizat. procedures in diabet. pts of
    55 yrs or more who have one or more of
    the foll. clin. findings: hypertens. (systol.
    pressure >160 mm Hg or diastol. pressure
    >90 mm Hg); high total cholesterol (>5.2
    mmol/L); low HDL (<0.9 mmol/L); current
    smoker; known microalbuminur.; clin.
    evidence of prev. vasc. dis., prevent.
    progress. ren. fail. in pts. suffer. from
    impair. ren. funct

    Tritace
    Sanofi
    RX
    partial basket chart
    Tritace

    ACE Inhibitor. Ramipril 1.25, 2.5, 5 mg.
    TABS: 28 x 1.25 mg, 2.5 mg, 5 mg.
    Hypertens., CCF, reduct. of mortality
    aft. M.I: Initial (for pt. not on diuretics):
    2.5 mg 1 x dly. May incr. at intervals of
    2-3 wks. up to 5 mg 1 x dly. to max. of
    10 mg 1 x dly. Reducing risk of M.I.,
    stroke or CV death and/or the need for
    revascularization procedures: Initial:
    2.5 mg 1 x dly. Depend. on tolerability,
    dose should be gradually increas. to
    double aft. about 1 wk. of tmt; then,
    aft. a further 3 wks, increase to 10 mg.
    Maint. dose: 10 mg 1 x dly. Pts already
    stabilised on lower doses for other
    indications where possible should be
    titrated to 10 mg 1 x dly.
    Hypertens. congest. heart fail., reduct.
    mortality aft. M.I., reduce risk M.I., stroke,
    CV death, need for revascularizat. in pts.
    over 55 yrs who have clinical evidence of
    CV dis. (prev. M.I., unstable angina,
    multivessel CABG or PTCA), stroke or
    periph. vasc. dis. Also for reducing risk of
    M.I., stroke, CV death or need for
    revascularizat. procedures in diabet. pts
    of 55 yrs or more who have one or more
    of the foll. clin. findings: hypertens.
    (systol. pressure >160 mm Hg or diastol.
    pressure >90 mm Hg); high total
    cholesterol (>5.2 mmol/L); low HDL (<0.9
    mmol/L); current smoker; known
    microalbuminur.; clin. evidence of prev.
    vasc. dis., prevent. progress. ren. fail. in
    pts. with persist. proteinur. in excess of 1
    g/day. Not suit. for tmt. hypertens. result.
    from prim. hyperaldosteronism.
    C/I: hypersens. histor. of angioed.
    2nd and 3rd trimester of reg., hypotens.
    Sig.bil. renal arter. stenos. See lit.

    Tritace Comp
    Sanofi
    RX
    partial basket chart
    Multiple ingredients
    Tritace Comp

    ACE Inhibitor, Thiazide. Hydrochlorothiazide 12.5 mg, 25 mg, Ramipril 2.5 mg, 5 mg.
    TABS: 28. Initial: 1 tab dly during or aft.
    meals. May incr. at intervals of 2-3 wks.
    if reqd. Max. dly dose: 10 mg
    ramipril/50 mg HTCZ. See lit.
    Essent. hypertens. when a comb. prep. is
    indicated.

    CLOSE